Jan 16
From Issuer Pays to Polluter Pays: Unearthing Piramal Pharma's Credit Ratings
Posted on 16th January, 2026 (GMT 01:48 hrs) ABSTRACT Piramal Pharma Limited (PPL), demerged from Piramal Enterprises in 2022, enjoys high investment-grade credit ratings (e.g., CARE AA; Stable upgraded July 2025) under the issuer-pays model, which critics claim manufactures trust to enable cheap borrowing despite severe financial strain—Q2 FY26 revenue down ~9% to ₹2,044 crore, EBITDA crashed…
#AcademicAuthenticity#AcademicCharade#AcademicIntegrity#Accountability#AgitPropTheatre#AjayPiramal#Ajay_Piramal_alleged_adverse_possessor#Ajay_Piramal_alleged_Contemnor#Ajay_Piramal_alleged_Environmental_Extortionist#Ajay_Piramal_Alleged_Insider_Trader#AuthoritarianPopulism_BJP#BeyondTheStage#BillionaireImpunity#BoycottPiramalProducts#Boycott_Godi_Media#BrandingIntellect#Cannibal_Capitalism#CapitalistCritique#CitizenVsCorporate#climatecrisis#ClimateJustice#ConsciousCapitalismExposed#CorporateCapture_DHFL#CorporateEthics#CorporateExploitation#CorporateLegalHarassment#CorporatePower#CorporateSpectacle#CorporateStateNexus#CrisisGovernance
